Lancet Oncology最新文献

筛选
英文 中文
Cancer and premature mortality-pushing the frontiers of cancer care. 癌症与过早死亡--推进癌症护理的前沿。
IF 41.6 1区 医学
Lancet Oncology Pub Date : 2024-08-01 Epub Date: 2024-07-01 DOI: 10.1016/S1470-2045(24)00327-9
Andrew Toyin Olagunju
{"title":"Cancer and premature mortality-pushing the frontiers of cancer care.","authors":"Andrew Toyin Olagunju","doi":"10.1016/S1470-2045(24)00327-9","DOIUrl":"10.1016/S1470-2045(24)00327-9","url":null,"abstract":"","PeriodicalId":17942,"journal":{"name":"Lancet Oncology","volume":null,"pages":null},"PeriodicalIF":41.6,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141534679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of pharmacy benefit managers on cancer health care. 药房福利管理机构对癌症医疗保健的影响。
IF 41.6 1区 医学
Lancet Oncology Pub Date : 2024-08-01 Epub Date: 2024-07-18 DOI: 10.1016/S1470-2045(24)00400-5
Priya Venkatesan
{"title":"Impact of pharmacy benefit managers on cancer health care.","authors":"Priya Venkatesan","doi":"10.1016/S1470-2045(24)00400-5","DOIUrl":"10.1016/S1470-2045(24)00400-5","url":null,"abstract":"","PeriodicalId":17942,"journal":{"name":"Lancet Oncology","volume":null,"pages":null},"PeriodicalIF":41.6,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141734511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dose selection of novel anticancer drugs: exposing the gap between selected and required doses. 新型抗癌药物的剂量选择:揭示所选剂量与所需剂量之间的差距。
IF 41.6 1区 医学
Lancet Oncology Pub Date : 2024-08-01 DOI: 10.1016/S1470-2045(24)00134-7
Catharina J P Op 't Hoog, Niven Mehra, Marc Maliepaard, Kalijn Bol, Hans Gelderblom, Gabe S Sonke, Adrianus J de Langen, Niels W C J van de Donk, Jeroen J W M Janssen, Monique C Minnema, Nielka P van Erp, Emmy Boerrigter
{"title":"Dose selection of novel anticancer drugs: exposing the gap between selected and required doses.","authors":"Catharina J P Op 't Hoog, Niven Mehra, Marc Maliepaard, Kalijn Bol, Hans Gelderblom, Gabe S Sonke, Adrianus J de Langen, Niels W C J van de Donk, Jeroen J W M Janssen, Monique C Minnema, Nielka P van Erp, Emmy Boerrigter","doi":"10.1016/S1470-2045(24)00134-7","DOIUrl":"https://doi.org/10.1016/S1470-2045(24)00134-7","url":null,"abstract":"<p><p>Historically, dose selection of anticancer drugs has mainly been based on establishing the maximum tolerated dose in phase 1 clinical trials with a traditional 3 plus 3 design. In the era of targeted therapies and immune-modulating agents, this approach does not necessarily lead to selection of the most favourable dose. This strategy can introduce potentially avoidable toxicity or inconvenience for patients. Multiple changes in drug development could lead to more rational dose selection, such as use of better predictive preclinical models, adaptive and randomised trial design, evaluation of multiple dose levels in late-phase development, assessment of target activity and saturation, and early biomarker use for efficacy and safety evaluation. In this Review, we evaluate the rationale and validation of dose selection in each phase of drug development for anticancer drugs approved by the European Medicines Agency and US Food and Drug Administration from Jan 1, 2020, to June 30, 2023, and give recommendations for dose optimisation to improve safety and patient convenience. In our evaluation, we classified 20 (65%) of the 31 recently registered anticancer agents as potential candidates for dose optimisation, which could be achieved either by reducing the dose (n=10 [32%]) or adjusting the dosage regimen (n=10 [32%]). Dose selection seemed to be adequately justified for nine (29%) of the drugs, whereas the reviewed data were inconclusive for formulating a recommendation on dose optimisation for two (6%) of the drugs.</p>","PeriodicalId":17942,"journal":{"name":"Lancet Oncology","volume":null,"pages":null},"PeriodicalIF":41.6,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141875171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating the KEYNOTE-057 trial's findings: addressing demographic, methodological, and economic considerations. 评估 KEYNOTE-057 试验结果:解决人口、方法和经济方面的问题。
IF 41.6 1区 医学
Lancet Oncology Pub Date : 2024-08-01 DOI: 10.1016/S1470-2045(24)00333-4
Shen Wang
{"title":"Evaluating the KEYNOTE-057 trial's findings: addressing demographic, methodological, and economic considerations.","authors":"Shen Wang","doi":"10.1016/S1470-2045(24)00333-4","DOIUrl":"https://doi.org/10.1016/S1470-2045(24)00333-4","url":null,"abstract":"","PeriodicalId":17942,"journal":{"name":"Lancet Oncology","volume":null,"pages":null},"PeriodicalIF":41.6,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141875172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lifestyle factors driving cancer cases and mortality in the USA. 美国癌症发病率和死亡率的生活方式因素。
IF 41.6 1区 医学
Lancet Oncology Pub Date : 2024-08-01 Epub Date: 2024-07-18 DOI: 10.1016/S1470-2045(24)00398-X
Karl Gruber
{"title":"Lifestyle factors driving cancer cases and mortality in the USA.","authors":"Karl Gruber","doi":"10.1016/S1470-2045(24)00398-X","DOIUrl":"10.1016/S1470-2045(24)00398-X","url":null,"abstract":"","PeriodicalId":17942,"journal":{"name":"Lancet Oncology","volume":null,"pages":null},"PeriodicalIF":41.6,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141734512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to Lancet Oncol 2024; 25: e374-87. Lancet Oncol 2024; 25: e374-87 更正。
IF 41.6 1区 医学
Lancet Oncology Pub Date : 2024-08-01 DOI: 10.1016/S1470-2045(24)00337-1
{"title":"Correction to Lancet Oncol 2024; 25: e374-87.","authors":"","doi":"10.1016/S1470-2045(24)00337-1","DOIUrl":"https://doi.org/10.1016/S1470-2045(24)00337-1","url":null,"abstract":"","PeriodicalId":17942,"journal":{"name":"Lancet Oncology","volume":null,"pages":null},"PeriodicalIF":41.6,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141875170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary cardiac angiosarcoma presenting as restrictive cardiomyopathy. 原发性心脏血管肉瘤表现为局限性心肌病。
IF 41.6 1区 医学
Lancet Oncology Pub Date : 2024-08-01 DOI: 10.1016/S1470-2045(24)00325-5
Joshua M Peterson, Adam Gonzalez, Juan P Olano, Suimin Qiu, Tejo Musunuru, Kirill A Lyapichev
{"title":"Primary cardiac angiosarcoma presenting as restrictive cardiomyopathy.","authors":"Joshua M Peterson, Adam Gonzalez, Juan P Olano, Suimin Qiu, Tejo Musunuru, Kirill A Lyapichev","doi":"10.1016/S1470-2045(24)00325-5","DOIUrl":"10.1016/S1470-2045(24)00325-5","url":null,"abstract":"","PeriodicalId":17942,"journal":{"name":"Lancet Oncology","volume":null,"pages":null},"PeriodicalIF":41.6,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141875174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Two-physician certification in end-of-life decision making. 临终决策中的双医认证。
IF 41.6 1区 医学
Lancet Oncology Pub Date : 2024-08-01 DOI: 10.1016/S1470-2045(24)00370-X
Abigail P Sneider, Valerie Gutmann Koch, Andrew Hantel, Peter Angelos
{"title":"Two-physician certification in end-of-life decision making.","authors":"Abigail P Sneider, Valerie Gutmann Koch, Andrew Hantel, Peter Angelos","doi":"10.1016/S1470-2045(24)00370-X","DOIUrl":"10.1016/S1470-2045(24)00370-X","url":null,"abstract":"","PeriodicalId":17942,"journal":{"name":"Lancet Oncology","volume":null,"pages":null},"PeriodicalIF":41.6,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141875178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nigeria mandates reporting of all cancer diagnoses. 尼日利亚规定必须报告所有癌症诊断结果。
IF 41.6 1区 医学
Lancet Oncology Pub Date : 2024-08-01 Epub Date: 2024-07-04 DOI: 10.1016/S1470-2045(24)00381-4
Paul Adepoju
{"title":"Nigeria mandates reporting of all cancer diagnoses.","authors":"Paul Adepoju","doi":"10.1016/S1470-2045(24)00381-4","DOIUrl":"10.1016/S1470-2045(24)00381-4","url":null,"abstract":"","PeriodicalId":17942,"journal":{"name":"Lancet Oncology","volume":null,"pages":null},"PeriodicalIF":41.6,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141555148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Carcinogenicity of talc and acrylonitrile. 滑石粉和丙烯腈的致癌性。
IF 41.6 1区 医学
Lancet Oncology Pub Date : 2024-08-01 Epub Date: 2024-07-05 DOI: 10.1016/S1470-2045(24)00384-X
Leslie T Stayner, Tania Carreón-Valencia, Paul A Demers, Jason M Fritz, Malcolm R Sim, Patricia Stewart, Hiroyuki Tsuda, Andres Cardenas, Dario Consonni, Laurie Davies, Sara De Matteis, Emanuela Felley-Bosco, Andrew J Ghio, Thomas Göen, Yann Grosse, Alessandro F Gualtieri, P David Josephy, Stella Koutros, Igor Linhart, Henriqueta Louro, Katie M O'Brien, Simona Panzacchi, Laura Peña, Pavel Rössner, Joellen M Schildkraut, Aleksandr B Stefaniak, Nicolas Wentzensen, Pascal Wild, Yuanyuan Xu, Aline de Conti, Caterina Facchin, Roland Wedekind, Ayat Ahmadi, Jessica Blanco, Shirisha Chittiboyina, Shalini Kulasingam, Richard MacLehose, Melitah Motlhale, Sanam Shah, Eero Suonio, Heidi Mattock, Andrew Kunzmann, Federica Madia, Elisa Pasqual, Lamia Benbrahim-Tallaa, Mary K Schubauer-Berigan
{"title":"Carcinogenicity of talc and acrylonitrile.","authors":"Leslie T Stayner, Tania Carreón-Valencia, Paul A Demers, Jason M Fritz, Malcolm R Sim, Patricia Stewart, Hiroyuki Tsuda, Andres Cardenas, Dario Consonni, Laurie Davies, Sara De Matteis, Emanuela Felley-Bosco, Andrew J Ghio, Thomas Göen, Yann Grosse, Alessandro F Gualtieri, P David Josephy, Stella Koutros, Igor Linhart, Henriqueta Louro, Katie M O'Brien, Simona Panzacchi, Laura Peña, Pavel Rössner, Joellen M Schildkraut, Aleksandr B Stefaniak, Nicolas Wentzensen, Pascal Wild, Yuanyuan Xu, Aline de Conti, Caterina Facchin, Roland Wedekind, Ayat Ahmadi, Jessica Blanco, Shirisha Chittiboyina, Shalini Kulasingam, Richard MacLehose, Melitah Motlhale, Sanam Shah, Eero Suonio, Heidi Mattock, Andrew Kunzmann, Federica Madia, Elisa Pasqual, Lamia Benbrahim-Tallaa, Mary K Schubauer-Berigan","doi":"10.1016/S1470-2045(24)00384-X","DOIUrl":"10.1016/S1470-2045(24)00384-X","url":null,"abstract":"","PeriodicalId":17942,"journal":{"name":"Lancet Oncology","volume":null,"pages":null},"PeriodicalIF":41.6,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141559068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信